Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for August 2004
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Trust defends Alzheimer's drug spending review
Plans labelled a 'public scandal'..(more)

 Industry welcomes broadening of hypertension treatment
NICE publish new guidance..(more)

 Novartis claims Prexige safety advantage over rivals
Global launch being prepared..(more)

 New study highlights additional benefits of Aricept
NICE to update recommendations..(more)

 Commission continues pursuit of AstraZeneca
EC investigation into Losec protection clears internal hurdle..(more)

 Newcastle stem cell pioneers seeking industry partners
Pro-life groups criticise development..(more)

 Sculptra receives FDA approval for HIV patients
Sculptra approved for facial fat loss..(more)

 Novartis to ace competition in new hypertension class
New drug to launch in 2006..(more)

 Barker named new ABPI chief
Industry and NHS facing challenges..(more)

 MabThera use to double with first line indication
New indication approved for Europe..(more)

 FDA approves Lipitor for reducing heart attack risk
Trial stopped two years early..(more)

 Cautious welcome for government crackdown on extremists
Police powers increased..(more)

 NHS researchers to test cancer gene therapy
Expert committee gives go ahead..(more)

 Lilly to disclose clinical trial results
Other companies may follow suit..(more)

 Pharma to work with NPC on pre-launch updates
New bulletins to improve communication..(more)

 'Double boost' for Seoquel in bipolar disorder and dementia
Seroquel closing gap on rivals..(more)

 Asthma and hypertension next in POM to P revolution
World's first OTC statin launched..(more)

 Generics continue to harass GSK
New products may revive fortunes..(more)

 £4.2 billion PFI hospital investments given go-ahead
NHS Plan target on track..(more)

 New diabetes drug superior to Lantus, says Lilly
Exenatide has weight advantage..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.